SCHEMBL24117207

SCHEMBL24117207

CNc1ccc(/C=N/N=C/c2ccc(N=O)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.45
▸ HSD17B10 Q99714 5/20 0.45
▸ APP P05067 2/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ TSHR P16473 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ ADRA2A P08913 1/20 0.41
▸ ADRA2B P18089 1/20 0.41
▸ ADRA2C P18825 1/20 0.41
▸ CA12 O43570 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ LMNA P02545 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22198148 0.88 NPC1 (0.54) ALDH1A1HSD17B10APPNPC1RAB9A
SCHEMBL537959 0.85 ALDH1A1 (0.58) ALDH1A1HSD17B10APPTSHRCYP3A4
SCHEMBL22198286 0.80 LMNA (0.62) ALDH1A1APPNPC1RAB9ASMN1; SMN2
SCHEMBL22198250 0.80 NPC1 (0.71) ALDH1A1APPNPC1RAB9ASMN1; SMN2
SCHEMBL9242348 0.79 ALDH1A1 (0.52) ALDH1A1HSD17B10APPSMN1; SMN2TSHR
SCHEMBL22198267 0.78 ALDH1A1 (0.68) ALDH1A1HSD17B10APPNPC1RAB9A
SCHEMBL22198264 0.78 APP (0.45) ALDH1A1APPNPC1RAB9ASMN1; SMN2
SCHEMBL22198276 0.78 GRIN2D (0.48) ALDH1A1APPNPC1RAB9ASMN1; SMN2
SCHEMBL22198268 0.78 GRIN2D (0.48) ALDH1A1APPNPC1RAB9ASMN1; SMN2
SCHEMBL22198265 0.78 NPC1 (0.48) ALDH1A1APPNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393810-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF HTA Co., Ltd. (CN) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393810-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF MAPT, APP, PSEN1 ALDH1A1 1343/4885HSD17B10 1254/4885APP 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback